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Abstract The epidemic of allergic disease in early life is
one of the clearest indicators that the developing immune
system is vulnerable to modern environmental changes.
A range of environmental exposures epidemiologically
associated with allergic disease have been shown to have
effects on the foetal immune function in pregnancy,
including microbial burden, dietary changes and environmen-
tal pollutants. Preliminary studies now suggest that these early
effects on immune development may be mediated
epigenetically through a variety of processes that collectively
modify gene expression and allergic susceptibility and that
these effects are potentially heritable across generations. It is
also possible that rising rates of maternal allergy, a recognised
direct risk factor for infant allergic disease, may be further
amplifying the effects of environmental changes. Whilst
effective prevention strategies are the ultimate goal in
reversing the allergy epidemic, the specific environmental
drivers, target genes, and intracellular pathways and
mechanisms of early life immune programming are still
unclear. It is hoped that identifying genes that are
differentially regulated in association with subsequent
allergic disease will assist in identifying causal pathways
and upstream contributing environmental factors. In this
way, epigenetic paradigms are likely to provide valuable
insights into how the early environment can be modified
to more favourably drive immune development and
reverse the allergic epidemic.
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Introduction
The immune system is exquisitely sensitive to environmen-
tal changes. One of the clearest reflections of this is the
recent and dramatic rise in virtually all immune diseases
with progressive modern urbanisation. Early development
of the immune system is dependent on environmental cues,
most notably from the colonising microflora, and that other
exposures, such as diet and environmental pollutants, may
also influence development in both the antenatal period and
soon thereafter. There is emerging evidence that the
epigenetic mechanisms that govern gene expression during
immune differentiation are susceptible to these environ-
mental influences. Whilst this plasticity in gene expression
may confer adaptability to environmental change, the
dramatic rise in allergic disease suggests that modern
environmental pressures could be adversely affecting these
developing pathways. Rising rates of allergic immune
disease in infancy also suggest that there may be critical
early periods of sensitivity. Effects on the epigenetic
regulation of these pathways are now being explored as a
mechanism for the long-observed gene–environmental
interactions.
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Changing prevalence of allergic disease
The rise in allergic disease first became evident in the more
industrially developed countries of Australasia, Western
Europe and North America where more than 40% of the
population may be affected at some stage in their lives
(Hopper et al. 1995; Peat et al. 1994). However, the same
patterns are now emerging in virtually all regions of the
world undergoing industrial development and westernization
(Asher et al. 2006). Burgeoning rates of allergic disease in
populous developing countries in Asia, Africa and South
America (Asher et al. 2006) highlight that this is fast
becoming a major global health issue. Even remote island
populations in Papua New Guinea are experiencing rising
rates of allergy as the western lifestyle encroaches
(Herbert et al. 2009). This is also an indication that
environmental changes can affect immune function irrespec-
tive of genetic background. However, there is some evidence
that non-Caucasian races may even be more susceptible to
allergic disease (Leung et al. 1994; Sicherer et al. 2010). For
example, several studies suggest that Asian populations may
be more susceptible to allergic disease when living in
‘westernised’ environments (Leung et al. 1994; Sicherer et
al. 2010). Earlier studies of respiratory disease observed that
both allergic symptoms and sensitisation were more common
in Asian Australians than non-Asian Australians (Leung
et al. 1994). Rates were also higher in Australian-born Asians
than Asian immigrants, with the prevalence increasing with
length of stay in Australia (Leung et al. 1994). Studies in the
USA have similarly noted that non-white races are more
susceptible to food allergy, particularly Asian populations
(Sicherer et al. 2010), suggesting a genetic propensity that
may be amplified in a western environment. This has major
implications as the heavily populated regions of Asia are
becoming rapidly urbanised, westernised and industrialised.
Another emerging phenomenon is the ‘second wave’ of
allergic disease (Prescott and Allen 2011) now occurring in
the most Westernised regions. Whilst the ‘first wave’ of
allergic diseases such as asthma and allergic rhinitis gained
momentum over 50 years ago, a ‘second wave’ of food
allergy has emerged only very recently, becoming most
evident in the last 10–15 years (Gupta et al. 2007). Over
this period, a striking increase in food allergy has been most
dramatic in the very same countries that lead the respiratory
epidemic, including the UK, Australia and the USA (Gupta
et al. 2007; Mullins 2007; Liu et al. 2010a), whereas
aeroallergen allergic disease has reached a plateau or even
begun to decline (Gupta et al. 2007; Robertson et al. 2004).
This increasing burden of food allergy anaphylaxis is most
evident in preschool children (Mullins 2007). These
temporal difference between different allergic conditions
and apparent intergenerational differences in the profile of
disease are still puzzling, but could suggest either continuing
changes in the environmental pressures over time or other
modifying effects between generations (below). At this stage,
the specific environmental factors driving this progressive
vulnerability to disease have not been clearly defined, but
most likely include progressively cleaner environments
(Strachan 2000), more pro-inflammatory Western style
diets (West et al. 2010), environmental contaminants and
pollutants (Baccarelli and Bollati 2009; Ponsonby et al.
2001; Liu et al. 2008), and maternal transmission of
antigens during pregnancy or soon thereafter (DesRoches
et al. 2010). Most notably, there is now evidence that these
environmental exposures can modify early immune gene
expression through potentially heritable epigenetic
changes (Liu et al. 2008; Schaub et al. 2009; Hollingsworth
et al. 2008; Perera et al. 2009; Baccarelli et al. 2009).
Although in its infancy in relation to complex diseases,
epigenetic research provides a new perspective and likely
mediator of the majority of gene–environment interactions.
Developmental origins of allergic disease
Developing systems are especially vulnerable to the effects
of adverse environmental exposures. This has led to
obvious interest in the early life origins of a wide range
of diseases that are linked to environmental change (Barker
1998). Such ‘foetal programming’ was first described in the
context of long-term effects of intrauterine environment on
offspring (Koldovsky 1979) and subsequently developed by
Barker and colleagues in the early 1990s (Barker and Fall
1993). The ‘foetal origins’ hypothesis (as it is now known)
is supported by a large number of studies in animals and
fewer largely epidemiological studies in humans (reviewed
in Waterland and Michels 2007). Structure, function and
response patterns of many systems are programmed during
this period, and early deviations may provide valuable
insights into the pathogenesis of disease as well as the
pathways of environmental influence. In the context of
immune development, there is consistent evidence of
differences in the immune function of neonates that go on
to develop allergic diseases (Prescott 2003; Prescott and
Clifton 2009), also suggesting foetal origins of these
common immune disorders. Whilst some of these differences
are likely to be conferred, at least in part, by genetic
inheritance, this does not explain the significant rise in
disease, which is frequently first manifest within only weeks
or months of birth. A range of environmental exposure in
pregnancy have been shown to modify immune function,
including maternal diet (Dunstan et al. 2003), microbial
exposure (Schaub et al. 2009; Prescott et al. 2008) and
pollutants such as cigarette smoke (Noakes et al. 2003),
notably the same culprits identified as potential immune
modifiers in epidemiological studies of allergic disease. A
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better understanding of these early interactions may also
provide opportunities for early intervention and disease
prevention.
Epigenetic programmes govern early development
From a single cell, we develop into complex multicellular
organisms. This vast cellular diversity is achieved by a
tightly regulated, yet imperfect (and plastic), developmental
epigenetic programme which contributes to the varied
patterns of gene expression both temporally and in a
tissue-specific fashion. Achieving the complexity inherent
in mammalian development requires the establishment of a
‘blank slate’ in the very early embryo that can be
selectively rewritten (‘programmed’) as progenitor cells
give rise to heterogeneous daughter cells as part of various
developmental cascades, producing different cell types and,
ultimately, tissues within an individual. To achieve this,
genome-wide DNA demethylation occurs twice during
mammalian development (Monk et al. 1987): firstly during
the generation of germ cells in both males and females and
secondly following fertilization prior to blastogenesis. During
this time, gene-specific methylation marks of both the
maternal and paternal genomes are extensively erased before
lineage-specific marks are reestablished (Okada et al. 2010).
The epigenetic programme involves multiple ‘layers’
of regulation. Primary and secondary epigenetic marks
include covalent changes to DNA (methylation and
hydroxymethylation of cytosine within CpG dinucleotides)
and DNA-associated packaging proteins (histonemethylation,
acetylation, ubiquitination, phosphorylation). These marks in
turn attract macromolecular complexes that together
determine the higher order structure and function of a
genomic region, whether at the level of a gene promoter,
whole chromosome, or the entire genome. Higher order
epigenetic state encompasses the degree of DNA compaction,
replication timing and spatial positioning within the cell
nucleus (Klose and Bird 2006). The result is the highly
coordinated control of genomic activities such as gene
expression, DNA replication and cell division.
These mechanisms are all potentially subject to
modification in response to environmental changes, and
this may provide an adaptive advantage in some settings,
allowing changes in gene expression that may be more
beneficial under altered environmental conditions
(Symonds et al. 2009). Moreover, these epigenetic
modifications are potentially heritable, conferring the
same advantages to the offspring. In this way, the
epigenetic code provides plasticity of gene expression in
response to environmental changes, allowing more rapid
(yet potentially reversible) phenotypic adaptations across
generations than those associated with Darwinian selection.
Equally so, maladaptive changes as a result of potentially
adverse environmental exposures may also be transmitted
to future generations, increasing the risk of disease, as
demonstrated in animal models of allergic disease
(Hollingsworth et al. 2008).
Epigenetic regulation of immune development
The cellular differentiation that leads to immune system
development is also under clear epigenetic control. Best
characterised for T cells, differentiation into T helper 1
(Th1), Th2, Th17 and regulatory T cells (Treg) is governed
by underlying changes in DNA/histone methylation and/or
histone acetylation (as recently reviewed by Janson et al.
2009). In uncommitted naive CD4+ T cells, key cytokine
promoter regions are methylated and transcriptionally
repressed. Patterns of subsequent demethylation associated
with gene activation depend on the direction of lineage
commitment. When these cells progress into Th-1 lineage
commitment, they undergo progressive demethylation of
the interferon γ (IFNγ) gene promoter, with associated
increased transcriptional activity and production of IFNγ,
the defining signature of this lineage (White et al. 2002,
2006; Winders et al. 2004; Yano et al. 2003). Conversely,
commitment to the Th2 lineage (the predominant lineage at
birth) is associated with demethylation of Th2-associated
genes such as IL-4 (Janson et al. 2009), with concomitant
silencing (DNA methylation) of IFNγ (Janson et al. 2009;
Zhu et al. 2003; Sanders 2006). Chromatin remodelling at
the Th2 cytokine locus (IL4/IL5/IL13/RAD50) is also
essential for Th2 lineage commitment (Yamashita et al.
2004). The mechanics of this process are not fully
understood, but involve changes in permissive histone
modifications following T cell receptor signalling. These
modifications are orchestrated by site-specific enzymes
including histone acetyltransferases (HATs) and histone
deacetylases (HDACs). Removal of acetyl groups by
HDACs is generally associated with gene silencing,
whereas acetylation by HATs is associated with a more
open chromatin structure and enhanced gene transcription.
GATA-3 transcription factor appears essential to initiate the
cascade of epigenetic modifications that stabilize Th2 gene
expression signature and lineage commitment (Yamashita
et al. 2004). Commitment to the more recently identified
pro-inflammatory Th17 lineage is also regulated through
changes in histone acetylation (Janson et al. 2009).
Although the developmental role of this lineage is not
clear, there are significant correlations between Th17 and
Th2 function in early life (Schaub et al. 2008a), and it
appears likely that epigenetic processes similar to those
involved in Th1/Th2 commitment also control Th17 cell
fate determination (Akimzhanov et al. 2007). Finally,
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specific epigenetic signatures (DNA hypomethylation) are
associated with FOXP3 expression, a defining signature of
the Treg lineage (Janson et al. 2008; Polansky et al. 2008).
It has been shown that selective demethylation of the
evolutionarily conserved Treg-specific demethylated region
within the FOXP3 locus determines the expression of this
gene, which is critical for the establishment of a stable Treg
lineage (Polansky et al. 2008). Furthermore, the level of
FOXP3 demethylation is associated with more efficient
functional activities (suppressive capacity) of Tregs (Liu et
al. 2010b). Less is known about the epigenetic determinants
of other immune cell types, although specific epigenetic
marks are likely to play a key role in a broad range of
immune-related processes (Yang et al. 2008). Similarly, there
is still little understanding of the epigenetic events that
predispose to the tissue-specific manifestation of allergic
disease, i.e. in the skin, airways and other mucosal surfaces.
There is evidence that some antenatal exposures (such as
maternal smoking) affect airway development in the foetus
(Gilliland et al. 2000; Hylkema and Blacquiere 2009), but
the exact mechanisms are not clear. The dose, timing and
reversibility of any potential adverse exposure are also
important factors that still need further investigation.
The well-defined profile of epigenetic modifications
associated with Th lineage commitment, coupled with the
sensitivity of the early developmental period, has led to
speculation that factors that disrupt these pathways may
increase the risk of allergic disease (Vuillermin et al.
2009). Specifically, effects on DNA methylation and
endogenous HDAC that selectively inhibit certain pathways
(Th1 and T regulatory cell differentiation) may favour Th2-
associated allergic differentiation (Bousquet et al. 2004;
Miller and Ho 2008).
Developmental differences in gene expression in allergic
disease
Complex immunological mechanisms have evolved to
allow the foetal and maternal immune systems to coexist
during pregnancy. FOXP3+ Tregs are attracted to the
materno-foetal interface by human chorionic gonadotrophin
(Schumacher et al. 2009), and the maternal cellular immune
system adapts subtly to a ‘Th2 state’ in order to
downregulate Th1 IFNγ cell-mediated immune responses
to foetal antigens (Breckler et al. 2008; Wegmann et al.
1993). Neonatal immune responses reflect these maternal
events, with reduced Th1 function and relative dominance
of Th2 activity, with underlying epigenetic changes
driving these patterns of gene expression (Zaghouani et al.
2009). This reduced IFNγ expression in neonatal CD4+ T
cells (relative to adults) is associated with silencing
(hypermethylation) of the IFNγ promoter (White et al.
2002). In the postnatal period, there is suppression of the Th2
dominance with progressive Th1 maturation (Prescott et al.
1999), and this CD4+ maturation is accompanied by
progressive demethylation within the IFNγ promoter and
upregulated IFNγ transcriptional activity (White et al. 2006).
Allergic disease is associated with significant differences in
this pattern of immune development: firstly, in the neonatal T
cell function and, secondly, in the postnatal maturation patterns.
As noted above, in the neonatal period, there is consistent
evidence of presymptomatic differences in newborns that later
develop allergic disease. Of these, immaturity of Th1 function
has been the most consistent observation (reviewed in Prescott
2003). However, there is now preliminary evidence of
attenuated Treg function (Smith et al. 2008; Schaub et al.
2008b) and excessive innate inflammatory responses (Tulic
et al. 2011) compared with infants that remain non-allergic.
These abnormalities appear to culminate in an increased
propensity for uncontrolled Th2 immune responses in the
postnatal period, which is associated with attenuated Th1
maturation in early childhood (Tulic et al. 2011).
Because differences in immune function are evident at
birth in newborns that develop allergic disease, there is
intense interest in the prenatal factors that may be
alternatively programming neonatal immunity, particularly
exposures that can disrupt normal gene activation or
silencing associated with balanced neonatal immune
responses (Martino and Prescott 2010, 2011).
Preliminary evidence of epigenetic modifiers in allergic
disease
New findings suggest that a number of environmental
exposures can induce stable epigenetic changes in gene
expression, which can be passed to offspring and subsequent
generations (Schaub et al. 2009; Hollingsworth et al. 2008;
Vuillermin et al. 2009; Breton et al. 2009; Bobetsis et al.
2007). Many of these factors (Fig. 1) have previously
recognised effects, both on foetal immune function (Dunstan
et al. 2003; Noakes et al. 2003; Blumer et al. 2005, 2007)
and epidemiologic links with the allergy epidemic, including
microbial burden (Strachan 2000; Braun-Fahrlander et al.
2002), dietary changes (West et al. 2010) and environmental
pollutants (Ponsonby et al. 2001; Nowak et al. 1996).
Emerging epigenetic paradigms provide a new mechanism
for the observed effects on gene expression (Schaub et al.
2009; Hollingsworth et al. 2008; Vuillermin et al. 2009;
Breton et al. 2009; Bobetsis et al. 2007).
Microbial exposure in pregnancy
As one of the leading candidates in the allergy epidemic,
there has been a long-standing interest in the role of
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microbial exposure in early life. There is now compelling
evidence that several pathogens can disrupt host cell
epigenetic profile (Bobetsis et al. 2007; Gutierrez et al.
2004; Kitajima et al. 2008), influencing or mimicking
mechanisms involved in DNA methylation (Tao and
Robertson 2003; Graessmann and Graessmann 1988;
Kruger et al. 1989) and histone modification (Arbibe et al.
2007). Although most of the focus has been on postnatal
microbial effects, there is emerging evidence of intrauterine
effects. Human studies also show that allergy protection by in
utero microbial exposure in rural farming environments is
associated with enhanced neonatal Treg function, FOXP3
expression and associated epigenetic effects (hypomethylation)
of the FOXP3 gene (Schaub et al. 2009). Non-pathogenic
microbial strains (Acinetobacter lwoffii) have been isolated
from these environments and their effects examined further
in animal models. When administered to pregnant rodents,
these bacteria also have allergy-protective effects in the
offspring, an effect which is dependent on the increased
expression of IFNγ (Renz, 2010, personal communication).
Furthermore, this effect is epigenetically mediated by an
increase in H4 acetylation of the IFNγ promoter and
abolished by the inhibition of histone acetylation following
Garcinol treatment. These observations have provided new
dimensions to the ‘hygiene hypothesis’ and suggest that
declining microbial exposures may be contributing to allergic
predisposition by epigenetically modifying the patterns of
immune gene expression during critical periods of early
development (Vuillermin et al. 2009).
Maternal diet in pregnancy
Diet and nutrition in pregnancy have been central to the
cross-discipline notions of the ‘developmental origins’ of
many diseases (Waterland and Michels 2007). In the
context of allergic disease, modern dietary changes appear
to be providing less tolerogenic conditions during early
immune programming (reviewed in West et al. 2010). A
range of specific nutritional changes have been implicated
in the rising allergic propensity, including the decline in
omega 3 polyunsaturated fatty acids (n-3PUFA) (Dunstan et
al. 2003), soluble fibre (Maslowski et al. 2009), antiox-
idants and other vitamins (Devereux et al. 2007), based on
epidemiological associations and recognised immunological
effects. Variations in nutrient factors such as PUFA have
recognised immunological effects which are mediated by
Fig. 1 Environmental influences on early immune programming: an epigenetic perspective. This illustrates the environmental factors that have
been implicated as potential immune modifiers during early development in the prenatal and/or postnatal periods
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changes in eicosanoid derivates and other metabolic products
(resolvins; Calder 2009), oxidative cell membrane fluidity,
surface marker expression (Calder et al. 2002) and cell signal
transduction (Prescott et al. 2007). We have shown that
maternal supplementation with fish oil (n-3 PUFA) is
associated with effects on immune function (Dunstan et al.
2003) and T cell signalling (Prescott et al. 2007). However,
at this stage, it is not clear how/whether this is related to
epigenetic modifications. Similarly, antioxidants have been
shown to have effects on T cell regulation (Tan et al. 2005)
and induction of IL-12 production by antigen-presenting
cells (Utsugi et al. 2003). Theoretically, this could favour
development of Th1 and inhibit Th2 responses. There are
only limited data on the immunomodulatory role of maternal
dietary antioxidants during pregnancy (Devereux et al.
2002), but evidence that oxidative stressors can induce
epigenetic changes in disease risk (below) indirectly high-
lights a role for these pathways (Breton et al. 2009).
The first direct evidence that maternal dietary changes in
pregnancy can alter immune function and allergic outcomes
through epigenetic changes came from an animal model of
folate supplementation (Hollingsworth et al. 2008). This
model was based on the capacity of folate supplementation
to epigenetically modify gene expression through its role as
a dietary methyl donor for DNA (Ulrey et al. 2005). Folate
and other one-carbon transfer agents (choline and methionine)
function as essential methyl donors in all cells. Available
evidence from both animal and human studies suggests that
the effects of folate deficiency on DNA methylation are very
complex, being cell type- and target organ-dependent, and are
gene- and site-specific (Kim 2004; Jhaveri et al. 2001).
Multiple lines of evidence suggest a link between disruption
in the folate/one-carbon metabolism, changes in DNA
methylation, altered gene expression and disease predisposi-
tion. Animal studies have shown that prenatal feeding of a
methyl supplemented diet can increase DNA methylation
and decrease expression of genes in offspring (Cooney et al.
2002; Cropley et al. 2006; Waterland and Jirtle 2004; Wolff
et al. 1998), whilst limiting folate supply in humans results in
increasing levels of homocysteine and reduced DNA
methylation (Jacob et al. 1998). A high folate diet in
pregnant mice resulted in altered gene methylation patterns
and decreased transcriptional activity in the lung tissue of the
progeny with increased airways hyper reactivity, airway
eosinophilia and production of inflammatory chemokines
(Hollingsworth et al. 2008). These effects were associated
with increased methylation (silencing) of the runt-related
transcription factor 3 (Runx3), which has been separately
shown to protect against airway disease through the
induction of FOXP3+ Tregs (Klunker et al. 2009). Notably,
the effects were also heritably transmitted to subsequent
generation (Hollingsworth et al. 2008). The significance of
this in humans is not clear, although there have been several
epidemiological studies to correlate folic acid supplementa-
tion during pregnancy with increased risk of asthma and
respiratory disease in the infants (Håberg et al. 2009; Whitrow
et al. 2009). However, until this is understood more fully, it
is premature to change the current recommendations aimed
at preventing neural tube defects. The effects of diet are
potentially complex, and more studies are also needed to
examine the effects of related dietary nutrients, such as
vitamins B2, B6, B12, methionine and choline, which may
also be implicated in epigenetic effects through the effects on
folate-mediated one-carbon metabolism. These and other
dietary influences remain an important avenue of research,
with the potential to provide simple noninvasive strategies to
reduce the risk of disease.
Exposure to tobacco smoke and air pollutants
Cigarette smoke and inhaled pollutants have recognised
adverse effects in pregnancy, including effects on foetal
lung growth (Gilliland et al. 2000) and immune development
(Noakes et al. 2003). New studies now provide preliminary
evidence of epigenetic effects in pregnancy (Breton et al.
2009). Maternal smoking in pregnancy is associated with
early-onset wheezing and reduced lung function in the
offspring (Magnusson et al. 2005; Bisgaard et al. 2009).
The effects of smoking on health can also be passed to
grandchildren, as evidenced from studies where grand-
mothers but not mothers have smoked (Li et al. 2005).
Furthermore, children exposed to maternal tobacco smoke in
utero may develop aberrant DNA methylation on a global
and gene-specific scale (Breton et al. 2009). Limited data
also suggest that exposures to the ultrafine particulate matter
found in pollution may also change DNA methylation in
maternal and foetal DNA, possibly associated with altered
inflammatory response pathways (Belinsky et al. 2002a, b).
High levels of maternal exposure to traffic exhaust particles
have been associated with increased methylation of the
acyl-CoA synthetase long-chain family member 3
(ACSL3) and with the development of asthma symptoms
in children (Perera et al. 2009). New studies in mice also
show that exposure to diesel exhaust particles augments
the production of IgE after allergen sensitization through
the hypermethylation of IFNG and hypomethylation of the
IL4 locus (Liu et al. 2008). It is also likely that effects of
these pollutants are mediated, at least in part, by
recognised epigenetic effects of oxidative stress on NF-κB
activation, which can induce histone modifications and
chromatin remodelling of pro-inflammatory genes other
signal transduction pathways. As a potent source of
oxidative stress, cigarette smoke reduces HDAC activity
with NF-κB-induced expression of pro-inflammatory
cytokines in peripheral lung tissue (reviewed in Rahman
et al. 2004). In placental tissue, nicotine has also been
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shown to alter cytokine production via NFκB (Dowling et al.
2007). Changes in the cytokine milieu at the materno-foetal
interface could have further implications for foetal immune
programming and disease susceptibility (as further discussed
below). Although there is much to be clarified in this field,
there is no doubt that exposure to toxic exposures such as
cigarette smoke is harmful and should be avoided.
Other modern pollutants with possible epigenetic effects
Less is known about other modern products of industry and
agriculture that contaminate modern homes, food, clothing
and water sources. These include polychlorinated biphenyl
compounds (PCBs), organochlorine pesticides, dioxins and
phthalates, which are highly lipid-soluble and accumulate
in human tissue with age. Some of these products have
been readily measured in breast milk, cord blood and
placental tissue, highlighting the potential to influence
early development (Noakes et al. 2006). Many are
described as recognised ‘hormonal imposters’ because of
their potentially pro-Th2 ‘oestrogenic’ activity. These
have recognised immunosuppressive effects and may
favour IgE allergic responses (Narita et al. 2007) and
sensitisation (Fukuyama et al. 2010). Prenatal exposure to
pesticides has been associated with increased cord blood
IgE levels (Reichrtova et al. 1999) and with increased risk
of childhood asthma (Sunyer et al. 2005). Exposure to
heavy metals in this period has also been correlated with
changes in genomic DNA methylation in cord blood
(Pilsner et al. 2009). In contaminated regions, PCB
exposure has also been linked with higher IgE levels in
early childhood (Grandjean et al. 2010). Of relevance here
is that these and other contaminants have now been
associated with epigenetic effects (reviewed by Baccarelli
and Bollati 2009), including effects on global DNA
methylation patterns at the low-dose exposure found in
the ambient environment (Kim et al. 2010). In many
regions, strategies are being developed to reduce levels of
environmental contamination, with an associated decline
in the levels measurable in human adipose tissue since the
1970s (Noakes et al. 2006). Although allergic disease has
continued to rise in this period, this does not exclude a
role of these factors, particularly as epigenetic effects may
persist for several generations. These ‘modern’ exposures
are an important consideration in the rise of ‘modern’
diseases, although this will remain difficult to investigate
as only correlative studies are possible in humans.
Maternal allergy as an additional immune modifier
Maternal allergy is a strong determinant of allergic risk and
has a stronger influence than paternal allergy. This, together
with significant effects on neonatal immune function,
suggests direct materno-foetal interactions or other mater-
nally imprinted effects. It is possible that the rise in
maternal allergy may also be amplifying the effect of
environmental changes. This could be an additional factor
influencing the observed changes in the age of onset,
phenotype and severity of disease seen in the most recent
generations (Prescott and Allen 2011).
Allergic women appear to have modified immune
interactions with their foetus in pregnancy, with reduced
Th1 IFNγ responses to foetal antigens compared with non-
allergic women (Prescott et al. 2010). Differences in the
cytokine milieu at the materno-foetal interface could
therefore be implicated in the attenuated neonatal Th1
responses observed commonly in infants of atopic mothers
(Rinas et al. 1993). This suggests that the endogenous
effects of the maternal allergic phenotype may compound
the increasingly pro-allergic exogenous environment.
Perhaps more significantly, epigenetic changes induced
by environmental changes can be inherited across
generations, as seen in animal models of allergic disease
(Hollingsworth et al. 2008). It is possible that the increase
in allergic disease could reflect the epigenetic effects of
environmental changes in preceding generations, inducing
heritable changes in gene expression patterns that confer
increased disease risk. This phenomenon could add to the
difficulties in identifying causal pathways as relationships
between exposures and phenotype within a generation
may not reflect any temporal distortions of transgenerational
effects.
Conclusion
The dramatic and recent rise in allergic diseases and the
very early onset of disease suggest that in utero events have
a more critical influence on immune development and
allergic propensity than genomic inheritance. This is
supported by growing evidence that antenatal exposures
(such as maternal diet, microbial exposure and smoking)
can modify neonatal immune function and the risk of
subsequent disease. Now, new evidence that environmental
exposures may be altering disease predisposition through
epigenetic effects on foetal gene expression provide novel
insights into the mechanisms and causal pathways. Most
importantly, as epigenetic modifications are generally
reversible, this may lead to the development of novel
therapeutic interventions that may be effective in the
ultimate goal of arresting, or even reversing, the allergy
epidemic.
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